Description
This assay uses the Luminex® 200™ platform.
Clinicians! This assay is now available for clinical diagnostics under Laboratory Developed Tests (LDT) and fully regulated under the CLIA. For more information and to explore how this clinical assay (HDIFN9-Clin) can enhance your diagnostic capabilities, visit our patient diagnostics webpage.
Consider this assay for an in-depth analysis of nine critical interferon (IFN) biomarkers. The Human Interferon 9-Plex Discovery Assay® Array (HDIFN9) includes key interferons such as IFN-α-2, IFN-β, IFN-ε, IFN-γ, and IFN-ω, among others.
This panel is designed to provide a comprehensive view of the interferon response, which is crucial for understanding immune modulation, viral infections, and autoimmune diseases. For instance, IFN-γ is pivotal in the activation of macrophages and in the defense against intracellular pathogens, while IFN-β is commonly used in the treatment of multiple sclerosis due to its immunomodulatory effects.
Analyzing these biomarkers simultaneously offers valuable insights into the diverse roles of interferons in immune response and disease mechanisms, making it an essential tool for research into immunological and inflammatory conditions.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays